197 related articles for article (PubMed ID: 25342390)
1. Do environmental factors modify the genetic risk of prostate cancer?
Loeb S; Peskoe SB; Joshu CE; Huang WY; Hayes RB; Carter HB; Isaacs WB; Platz EA
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):213-20. PubMed ID: 25342390
[TBL] [Abstract][Full Text] [Related]
2. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
Chan JM; Darke AK; Penney KL; Tangen CM; Goodman PJ; Lee GM; Sun T; Peisch S; Tinianow AM; Rae JM; Klein EA; Thompson IM; Kantoff PW; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1050-1058. PubMed ID: 27197287
[TBL] [Abstract][Full Text] [Related]
3. TNF polymorphisms and prostate cancer risk.
Danforth KN; Rodriguez C; Hayes RB; Sakoda LC; Huang WY; Yu K; Calle EE; Jacobs EJ; Chen BE; Andriole GL; Figueroa JD; Yeager M; Platz EA; Michaud DS; Chanock SJ; Thun MJ; Hsing AW
Prostate; 2008 Mar; 68(4):400-7. PubMed ID: 18196539
[TBL] [Abstract][Full Text] [Related]
4. Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study.
Shebl FM; Sakoda LC; Black A; Koshiol J; Andriole GL; Grubb R; Church TR; Chia D; Zhou C; Chu LW; Huang WY; Peters U; Kirsh VA; Chatterjee N; Leitzmann MF; Hayes RB; Hsing AW
Br J Cancer; 2012 Jun; 107(1):207-14. PubMed ID: 22722313
[TBL] [Abstract][Full Text] [Related]
5. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
Cooper ML; Adami HO; Grönberg H; Wiklund F; Green FR; Rayman MP
Cancer Res; 2008 Dec; 68(24):10171-7. PubMed ID: 19074884
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies.
Danforth KN; Hayes RB; Rodriguez C; Yu K; Sakoda LC; Huang WY; Chen BE; Chen J; Andriole GL; Calle EE; Jacobs EJ; Chu LW; Figueroa JD; Yeager M; Platz EA; Michaud DS; Chanock SJ; Thun MJ; Hsing AW
Carcinogenesis; 2008 Mar; 29(3):568-72. PubMed ID: 17999989
[TBL] [Abstract][Full Text] [Related]
7. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
[TBL] [Abstract][Full Text] [Related]
8. Estimation of absolute risk for prostate cancer using genetic markers and family history.
Xu J; Sun J; Kader AK; Lindström S; Wiklund F; Hsu FC; Johansson JE; Zheng SL; Thomas G; Hayes RB; Kraft P; Hunter DJ; Chanock SJ; Isaacs WB; Grönberg H
Prostate; 2009 Oct; 69(14):1565-72. PubMed ID: 19562736
[TBL] [Abstract][Full Text] [Related]
9. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2017 Jun; 77(8):908-919. PubMed ID: 28317149
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.
Daugherty SE; Shugart YY; Platz EA; Fallin MD; Isaacs WB; Pfeiffer RM; Welch R; Huang WY; Reding D; Hayes RB
Prostate; 2007 Oct; 67(14):1487-97. PubMed ID: 17680641
[TBL] [Abstract][Full Text] [Related]
11. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
Liss MA; Xu J; Chen H; Kader AK
Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk.
Barry KH; Koutros S; Andreotti G; Sandler DP; Burdette LA; Yeager M; Beane Freeman LE; Lubin JH; Ma X; Zheng T; Alavanja MC; Berndt SI
Carcinogenesis; 2012 Feb; 33(2):331-7. PubMed ID: 22102698
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic and non-genetic risk factors with the development of prostate cancer in Malaysian men.
Munretnam K; Alex L; Ramzi NH; Chahil JK; Kavitha IS; Hashim NA; Lye SH; Velapasamy S; Ler LW
Mol Biol Rep; 2014; 41(4):2501-8. PubMed ID: 24443231
[TBL] [Abstract][Full Text] [Related]
14. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility loci, pesticide exposure and prostate cancer risk.
Koutros S; Berndt SI; Hughes Barry K; Andreotti G; Hoppin JA; Sandler DP; Yeager M; Burdett LA; Yuenger J; Alavanja MC; Beane Freeman LE
PLoS One; 2013; 8(4):e58195. PubMed ID: 23593118
[TBL] [Abstract][Full Text] [Related]
17. Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer.
Koutros S; Beane Freeman LE; Berndt SI; Andreotti G; Lubin JH; Sandler DP; Hoppin JA; Yu K; Li Q; Burdette LA; Yuenger J; Yeager M; Alavanja MC
Cancer Res; 2010 Nov; 70(22):9224-33. PubMed ID: 20978189
[TBL] [Abstract][Full Text] [Related]
18. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
[TBL] [Abstract][Full Text] [Related]
19. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer.
Julin B; Shui I; Heaphy CM; Joshu CE; Meeker AK; Giovannucci E; De Vivo I; Platz EA
Br J Cancer; 2015 Feb; 112(4):769-76. PubMed ID: 25562437
[TBL] [Abstract][Full Text] [Related]
20. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
